Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

Abstract

Rett syndrome1 (RTT, MIM 312750) is a progressive neurodevelopmental disorder and one of the most common causes of mental retardation in females, with an incidence of 1 in 10,000–15,000 (ref. 2). Patients with classic RTT appear to develop normally until 6–18 months of age, then gradually lose speech and purposeful hand use, and develop microcephaly, seizures, autism, ataxia, intermittent hyperventilation and stereotypic hand movements3. After initial regression, the condition stabilizes and patients usually survive into adulthood. As RTT occurs almost exclusively in females, it has been proposed that RTT is caused by an X-linked dominant mutation with lethality in hemizygous males3,4,5,6,7,8. Previous exclusion mapping studies using RTT families mapped the locus to Xq28 (refs 6,9,10,11). Using a systematic gene screening approach, we have identified mutations in the gene (MECP2 ) encoding X-linked methyl-CpG-binding protein 2 (MeCP2) as the cause of some cases of RTT. MeCP2 selectively binds CpG dinucleotides in the mammalian genome and mediates transcriptional repression through interaction with histone deacetylase and the corepressor SIN3A (refs 12,13). In 5 of 21 sporadic patients, we found 3 de novo missense mutations in the region encoding the highly conserved methyl-binding domain (MBD) as well as a de novo frameshift and a de novo nonsense mutation, both of which disrupt the transcription repression domain (TRD). In two affected half-sisters of a RTT family, we found segregation of an additional missense mutation not detected in their obligate carrier mother. This suggests that the mother is a germline mosaic for this mutation. Our study reports the first disease-causing mutations in RTT and points to abnormal epigenetic regulation as the mechanism underlying the pathogenesis of RTT.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: MECP2 mutations in sporadic RTT patients.
Figure 2: Mutations in the family of affected half-sisters.
Figure 3: Alignment of MeCP2 sequences from different species with the positions of the mutations in RTT.

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Rett, A. Uber ein zerebral-atrophisches Syndrome bei Hyperammonemie (Bruder Hollinek, Vienna, 1966).

    Google Scholar 

  2. Hagberg, B. Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr. Scand. 74, 405– 408 (1985).

    Article  CAS  Google Scholar 

  3. Hagberg, B., Aicardi, J., Dias, K. & Ramos, O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann. Neurol. 14, 471–479 (1983).

    Article  CAS  Google Scholar 

  4. Zoghbi, H. Genetic aspects of Rett syndrome. J. Child Neurol. 3, S76–78 (1988).

    Article  Google Scholar 

  5. Zoghbi, H.Y., Percy, A.K., Schultz, R.J. & Fill, C. Patterns of X chromosome inactivation in the Rett syndrome. Brain Dev. 12, 131–135 (1990).

    Article  CAS  Google Scholar 

  6. Ellison, K.A. et al. Examination of X chromosome markers in Rett syndrome: exclusion mapping with a novel variation on multilocus linkage analysis. Am. J. Hum. Genet. 50, 278–287 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Schanen, N.C. et al. A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am. J. Hum. Genet. 61, 634–641 (1997).

    Article  CAS  Google Scholar 

  8. Schanen, C. & Francke, U. A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. Am. J. Hum. Genet. 63, 267–269 (1998).

    Article  CAS  Google Scholar 

  9. Archidiacono, N. et al. Rett syndrome: exclusion mapping following the hypothesis of germinal mosaicism for new X-linked mutations. Hum. Genet. 86, 604–606 (1991).

    Article  CAS  Google Scholar 

  10. Curtis, A.R. et al. X chromosome linkage studies in familial Rett syndrome. Hum. Genet. 90, 551–555 (1993).

    Article  CAS  Google Scholar 

  11. Sirianni, N., Naidu, S., Pereira, J., Pillotto, R.F. & Hoffman, E.P. Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am. J. Hum. Genet. 63, 1552–1558 (1998).

    Article  CAS  Google Scholar 

  12. Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386–389 (1998).

    Article  CAS  Google Scholar 

  13. Jones, P.L. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet. 19, 187– 191 (1998).

    Article  CAS  Google Scholar 

  14. Amir, R., Roth Dahle, E., Toniolo, D. & Zoghbi, H.Y. Candidate gene analysis in Rett syndrome and the identification of twenty-one SNPs in Xq. Am. J. Med. Genet. (in press).

  15. Wan, M. & Francke, U. Evaluation of two X chromosomal candidate genes for Rett syndrome: glutamate dehydrogenase-2 (GLUD2) and rab GDP-dissociation inhibitor (GDI1). Am. J. Med. Genet. 78, 169–172 ( 1998).

    Article  CAS  Google Scholar 

  16. D'Esposito, M. et al. Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mamm. Genome 7, 533–535 (1996).

    Article  CAS  Google Scholar 

  17. Lewis, J.D. et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905–914 (1992).

    Article  CAS  Google Scholar 

  18. Nan, X., Meehan, R.R. & Bird, A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 21, 4886–4892 (1993).

    Article  CAS  Google Scholar 

  19. Nan, X., Campoy, F.J. & Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88, 471 –481 (1997).

    Article  CAS  Google Scholar 

  20. Allen, R.C., Zoghbi, H.Y., Moseley, A.B., Rosenblatt, H.M. & Belmont, J.W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am. J. Hum. Genet. 51, 1229–1239 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Tate, P., Skarnes, W. & Bird, A. The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nature Genet. 12 , 205–208 (1996).

    Article  CAS  Google Scholar 

  22. Coy, J.F., Sedlacek, Z., Bachner, D., Delius, H. & Poustka, A. A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3′-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum. Mol. Genet. 8, 1253–1262 (1999).

    Article  CAS  Google Scholar 

  23. Hendrich, B. & Bird, A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18, 6538–6547 ( 1998).

    Article  CAS  Google Scholar 

  24. Hendrich, B. et al. Genomic structure and chromosomal mapping of the murine and human mbd1, mbd2, mbd3, and mbd4 genes. Mamm. Genome 10, 906–912 (1999).

    Article  CAS  Google Scholar 

  25. Ganguly, A., Rock, M.J. & Prockop, D.J. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc. Natl Acad. Sci. USA 90, 10325– 10329 (1993); erratum: 91, 5217 (1994).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the Rett families for their participation and for motivating us as we sought the cause of this disease; the Blue Bird Circle Rett Center, D.G. Glaze and R.J. Schultz for following patients and facilitating sample collection; E.J.R. Dahle for previous research contributions; and A.L. Beaudet for discussions and critical review of the manuscript. This research was supported by the Howard Hughes Medical Institute and NIH grants HD24234 (H.Y.Z. and U.F.) and MRRC HD 24064, the International Rett Syndrome Association (R.A.), the Society for Gynecologic Investigation (I.V.) and the L.M. Chandler Research Fund (M.W.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huda Y. Zoghbi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amir, R., Van den Veyver, I., Wan, M. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23, 185–188 (1999). https://doi.org/10.1038/13810

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/13810

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing